Atomwise logo

Atomwise

Better Medicines Faster

13 employees · est. 2012 · San Francisco, United States

VS
Novalix logo

Novalix

Novalix is a premier drug discovery CRO

371 employees · est. 2002 · Strasbourg, France

Novalix is the older company (2012 vs 2002); Novalix is the larger of the two.

Side-by-Side Comparison

Atomwise Novalix
Founded
2012 2002 older
Headquarters
San Francisco, United States Strasbourg, France
Employees
13 371 larger
Industry
AI, Biotechnology, Health Care Biotechnology
Funding Stage
Grant Corporate Round
Total Funding
$176.65M $2.00M
Funding Rounds
9 2
Services
AI-based drug discovery, Immune and inflammatory disease therapeutics, Chemical space exploration Drug discovery, pharmacology, biophysics, chemistry, cosmetics, consulting services, technical services
Target Customers
Pharmaceutical companies, Biotechnology firms, Medical researchers, Healthcare providers Biotech firms, pharmaceutical companies, research and development departments, clinical development teams
Taxonomy
AI Drug Discovery, Deep Learning, Structure-Based Drug Discovery, Small-Molecule Drug Candidates, Preclinical Studies, Undruggable Targets, Pharmaceutical Partnerships, Agrochemical Collaboration, Biotechnology Collaboration, Scientific Advisory Board, Venture Capital Funding, Drug Discovery Platform, Life Sciences Innovation, Computer-Aided Drug Design Drug Discovery, Biophysical Technologies, Outsourcing, SPR Technology, X-ray Protein Crystallography, NMR Technologies, Medicinal Chemistry, Structural Biology, Chemical Development, Biologics Analysis, Pharmaceutical Development, Manufacturing Support, Epigenetic Targets, Native Mass Spectrometry, Flow Chemistry
Website
atomwise.com novalix.com
Atomwise logo

About Atomwise

Atomwise, founded in 2012, is a pioneering preclinical pharma company based in the United States. Operating at the intersection of AI, Biotechnology, and Health Care, it aims to deliver on its slogan: Better Medicines Faster. The company has set a milestone by expanding its Board of Directors and c...

Novalix logo

About Novalix

Novalix is a premier drug discovery CRO providing services to biotech firms and pharmaceutical companies. The company, founded in 2002, emphasizes the significance of exceptional scientific talent and exclusive resources, offering a range of platforms to improve the success rate during pre-clinical...

We will tell you when either one moves

BounceWatch watches Atomwise and Novalix for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Atomwise and Novalix — by email.

Frequently Asked Questions

Atomwise — Better Medicines Faster. Novalix — Novalix is a premier drug discovery CRO. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Atomwise has raised $176.65M while Novalix has raised $2.00M.
Atomwise and Novalix operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Atomwise with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Atomwise on 21 Sep 2026, and Novalix on 7 Jun 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes